Immunohistochemical evaluation of CON6D/B5: A new CD30 monoclonal antibody

Applied Immunohistochemistry and Molecular Morphology

Volumn 18, Issue 3, 2010, Pages 273-277

  Lau, Sean K ^a   Thomas, Premi ^a   Weiss, Lawrence M ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Anaplastic large cell lymphoma; CD30; Embryonal carcinoma; Hodgkin lymphoma; Immunohistochemistry

Indexed keywords

CD30 ANTIGEN; FORMALDEHYDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER H2; MONOCLONAL ANTIBODY CON6D; PARAFFIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EMBRYONAL CARCINOMA; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; CARCINOMA, EMBRYONAL; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; EPITOPES; HODGKIN DISEASE; HUMANS; IMMUNOCHEMISTRY; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MICE; PARAFFIN EMBEDDING; SENSITIVITY AND SPECIFICITY;

EID: 77951742408     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181c81d31     Document Type: Article

References (16)

1. Dürkop H, Latza U, Hummel M, et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 1992;68: 421-427.
2. Falini B, Pileri S, Pizzolo G, et al. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood. 1995;85:1-14.
3. Horie R, Watanabe T. CD30: expression and function in health and disease. Semin Immunol. 1998;10:457-470.
4. Chiarle R, Podda A, Prolla G, et al. CD30 in normal and neoplastic cells. Clin Immunol. 1999;90:157-164.
5. Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature. 1982;299:65-67.
6. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66:848-858.
7. Pallesen G, Hamilton-Dutoit SJ. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am J Pathol. 1988;133:446-450.
8. Millward C, Weidner N. CD30 (Ber-H2) expression in nonhematopoietic tumors. Appl Immunohistochem. 1998;6:164-168.
9. Schwarting R, Gerdes J, Dürkop H, et al. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood. 1989;74:1678-1689.
10. Chang KL, Arber DA, Weiss LM. CD30: a review. Appl Immunohistochem. 1993;1:244-255.
11. Hittmair A, Rogatsch H, Hobisch A, et al. CD30 expression in seminoma. Hum Pathol. 1996;27:1166-1171.
12. Polski JM, Janney CG. Ber-H2 (CD30) immunohistochemical staining in malignant melanoma. Mod Pathol. 1999;12:903-906.
13. Garcia-Prats MD, Ballestin C, Sotelo T, et al. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumours. Histopathology. 1998;32: 462-472.
14. Dürkop H, Foss HD, Eitelbach F, et al. Expression of the CD30 antigen in non-lymphoid tissues and cells. J Pathol. 2000;190: 613-618.
15. Kneile JR, Tan G, Suster S, et al. Expression of CD30 (Ber-H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma- like carcinoma. A comparison study with anaplastic large cell lymphoma. Histopathology. 2006;48:855-861.
16. Mechtersheimer G, Möller P. Expression of Ki-1 antigen (CD30) in mesenchymal tumors. Cancer. 1990;66:1732-1737.